Assertio Therapeutics, Inc.
Sonraí clárlainne oifigiúla
0leantóir
2018bunaithe
Maidir le Assertio Therapeutics, Inc.
Assertio Therapeutics, Inc. is an American specialty pharmaceutical company. It mainly markets products for treatment in neurology, pain and diseases of the central nervous system. Depomed was founded in 1995 and is headquartered in Newark, California. It is a publicly traded company on NASDAQ, with several products approved by the United States Food and Drug Administration (FDA). On August 15, 2018, the company announced its name change from Depomed, Inc., to Assertio Therapeutics, Inc. As of 2019, Assertio markets three products approved by the FDA: Gralise, Cambia, and Zipsor.
Source: Wikipedia
Ceanncheathrú251 LITTLE FALLS DRIVE, 19808, WILMINGTON, US
Bunaithe2018
StádasGníomhach
Paitinní1 paitinn
GASTRIC RETENTIVE PHARMACEUTICAL COMPOSITIONS FOR TREATMENT AND PREVENTION OF CNS DISORDERSEP2326310B1 · 2019
Léirmheasanna
Níl aon léirmheas fós. Ar oibrigh tú le Assertio Therapeutics, Inc.? Bí ar an gcéad duine a roinneann do thaithí.
Faisnéis dhlíthiúil
| Ainm dlíthiúil | Assertio Therapeutics, Inc. |
|---|---|
| LEI | 549300L2A9NTF1JVDP20Féach ar GLEIF ↗ |
| Seoladh cláraithe | 251 LITTLE FALLS DRIVE, 19808, WILMINGTON, US |
| Stádas | Gníomhach |
Foinsí: GLEIF · nuashonraithe 16 Deireadh Fómhair 2026
Teagmháil agus naisc
Suíomh
251 LITTLE FALLS DRIVE, 19808, WILMINGTON, US
An í seo do chuideachta?
Éiligh an leathanach seo saor in aisce chun do lógó, táirgí, grianghraif agus poist a chur leis, agus chun léirmheasanna a fhreagairt.
Éiligh an leathanach seoCláraigh le Heelky chun nascadh, fostú agus fás
Cruthaigh cuntas saor in aisce chun teachtaireachtaí a sheoladh chuig daoine, iarratas a dhéanamh ar phoist agus misin a phostáil.
Glac páirt anois — tá sé saor in aisce